Glycoconj J
1-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-
enopyranosyl)-(2-(4-fluorophenyl)ethynyl ) (8a) H NMR
4.9 Hz, 3H), 5.96 (ddd, J = 10.2, 3.4, 1.8 Hz, 1H), 5.80 (dt,
J = 10.2, 1.9 Hz, 1H), 5.17–5.11 (m, 1H), 5.07 (ddd, J = 8.2,
3.9, 1.9 Hz, 1H), 4.08 (dq, J = 12.6, 6.3 Hz, 1H), 2.10 (s, 3H),
1.29 (d, J = 6.3 Hz, 3H). HRMS (ESI): m/z Calculated for
[M + Na]+ C16H16O3Na 279.0992, found 279.0997.
1
(500 MHz, CDCl3) δ 7.42 (dd, J = 8.5, 5.4 Hz, 2H), 7.01 (t,
J = 8.6 Hz, 2H), 6.13 (dd, J = 9.9, 3.6 Hz, 1H), 6.09–6.02 (m,
1H), 5.25 (d, J = 1.3 Hz, 1H), 5.11 (dd, J = 4.9, 2.0 Hz, 1H),
4.42 (t, J = 5.9 Hz, 1H), 4.31 (dd, J = 11.5, 5.3 Hz, 1H), 4.22
(dd, J = 11.4, 7.3 Hz, 1H), 2.08 (d, J = 13.4 Hz, 6H). 13C NMR
(125 MHz, CDCl3) δ 170.66, 170.36, 162.71 (d,
JcF = 247.5 Hz), 133.77, 133.70, 131.82, 122.49, 118.12 (d,
JcF = 3.5 Hz), 115.71, 115.53, 85.75, 83.74, 69.65, 64.27,
63.21, 62.74, 20.80, 20.75. HRMS (ESI): m/z Calculated for
[M + Na]+ C18H17FO5Na 355.0952, found 355.0966.
1-(4-O-acetyl-2,3,6-trideoxy-α-L-erythro-hex-2-
enopyranosyl)-(2-(4-fluorophenyl)ethynyl ) (13a) 1H NMR
(500 MHz, CDCl3) δ 7.44 (dd, J = 8.5, 5.5 Hz, 2H), 7.04–6.97
(m, 2H), 5.94 (ddd, J = 10.1, 2.7, 1.7 Hz, 1H), 5.80 (d,
J = 10.2 Hz, 1H), 5.12 (d, J = 1.3 Hz, 1H), 5.07 (dd,
J = 8.1, 1.7 Hz, 1H), 4.09–4.02 (m, 1H), 2.10 (s, 3H), 1.29
(d, J = 6.3 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 170.51 s),
162.65(d, JcF = 247 Hz), 133.78 (2C), 129.17, 125.71,
118.43, 115.65, 115.47, 85.25, 84.91, 70.24, 68.22, 63.74,
21.10, 18.05. HRMS (ESI): m/z Calculated for [M + Na]+
C16H15FO3Na 298.0897, found 298.0899.
1-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-
1
enopyranosyl)-(2-(4-pentylphenyl)ethynyl ) (9a) H NMR
(500 MHz, CDCl3) δ 7.35 (d, J = 8.2 Hz, 2H), 7.13 (d,
J = 8.2 Hz, 2H), 6.14 (dd, J = 10.1, 3.8 Hz, 1H), 6.05 (ddd,
J = 10.0, 5.4, 1.9 Hz, 1H), 5.26 (dd, J = 3.7, 1.9 Hz, 1H), 5.11
(dd, J = 5.4, 2.4 Hz, 1H), 4.44 (ddd, J = 7.5, 5.3, 2.4 Hz, 1H),
4.31 (dd, J = 11.5, 5.3 Hz, 1H), 4.21 (dd, J = 11.5, 7.3 Hz, 1H),
2.63–2.55 (m, 2H), 2.08 (d, J = 11.7 Hz, 6H), 1.60 (dd,
J = 14.2, 6.7 Hz, 2H), 1.31 (tdd, J = 12.9, 9.5, 3.5 Hz, 4H),
0.88 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ
170.74, 170.43, 144.03, 132.17, 131.73 (2C), 128.44 (2C),
122.31, 119.19, 87.10, 83.36, 69.64, 64.45, 63.38, 62.86,
35.83, 31.38, 30.87, 22.48, 20.87, 20.82, 13.98. HRMS
(ESI): m/z Calculated for [M + Na]+ C23H28O5Na 407.1829,
found 407.1839.
1-(4,6-di-O-benzoyl-2,3-dideoxy-α-D-erythro-hex-2-
enopyranosyl)-2-phenylacetylene(14a) 1H NMR (500 MHz,
CDCl3) δ 8.11–8.00 (m, 4H), 7.60–7.28 (m, 11H), 6.06 (ddd,
J = 10.2, 3.4, 1.8 Hz, 1H), 5.99 (dt, J = 10.2, 1.7 Hz, 1H), 5.71
(dd, J = 8.7, 1.8 Hz, 1H), 5.27 (dt, J = 3.5, 1.9 Hz, 1H), 4.65
(dd, J = 11.1, 1.8 Hz, 1H), 4.56–4.46 (m, 2H). HRMS (ESI):
m/z Calculated for [M + Na]+ C28H22O5Na 461.1359, found
461.1376.
1-(4,6-di-O-benzoyl-2,3-dideoxy-α-D-erythro-hex-2-
1
enopyranosyl)-(m-tolylethynyl) (15a) H NMR (500 MHz,
1-(4-O-acetyl-2,3-dideoxy-α-D-erythro-penta-2-
enopyranosyl)-2-phenylacetylene(10a) 1H NMR (500 MHz,
CDCl3) δ 7.44 (dd, J = 7.5, 1.8 Hz, 2H), 7.32 (t, J = 6.2 Hz,
3H), 6.14 (dd, J = 10.1, 3.6 Hz, 1H), 6.00 (dd, J = 10.0,
4.8 Hz, 1H), 5.20–5.14 (m, 1H), 5.10–5.03 (m, 1H), 4.27
(dd, J = 13.0, 3.0 Hz, 1H), 3.93 (d, J = 13.0 Hz, 1H), 2.11
(s, 3H). HRMS (ESI): m/z Calculated for [M + CH3OH +
Na]+ C16H18O4Na 297.1103, found 297.0629.
CDCl3) δ 8.05 (dd, J = 11.1, 4.1 Hz, 4H), 7.60–7.49 (m, 2H),
7.43 (t, J = 7.8 Hz, 2H), 7.36 (t, J = 7.8 Hz, 2H), 7.26–7.12 (m,
4H), 6.05 (ddd, J = 10.2, 3.4, 1.8 Hz, 1H), 5.98 (dt, J = 10.2,
1.7 Hz, 1H), 5.70 (dd, J = 8.7, 1.8 Hz, 1H), 5.26 (dt, J = 3.5,
1.8 Hz, 1H), 4.65 (dd, J = 10.9, 1.7 Hz, 1H), 4.51 (ddd,
J = 17.2, 8.7, 4.1 Hz, 2H), 2.32 (s, 3H). 13C NMR
(125 MHz, CDCl3) δ 166.34, 165.87, 138.00, 133.34,
132.96, 132.35, 129.85, 129.79 (2C), 129.74 (2C), 129.58,
129.54, 129.40, 128.86, 128.42 (2C), 128.26 (2C), 128.19,
125.78, 121.99, 86.75, 84.48, 70.35, 65.83, 64.63, 63.87,
21.17. HRMS (ESI): m/z Calculated for [M + Na]+
C29H24O5Na 475.1516, found 475.1527.
1-(4-O-acetyl-2,3-dideoxy-α-D-erythro-penta-2-
enopyranosyl)-(2-(4-fluorophenyl)ethynyl ) (11a) 1H NMR
(500 MHz, CDCl3) δ 7.42 (dd, J = 8.6, 5.4 Hz, 2H), 7.00 (t,
J = 8.6 Hz, 2H), 6.12 (dd, J = 9.9, 3.1 Hz, 1H), 6.00 (dd,
J = 9.3, 4.3 Hz, 1H), 5.15 (s, 1H), 5.07 (s, 1H), 4.25 (dd,
J = 12.9, 2.8 Hz, 1H), 3.93 (d, J = 12.9 Hz, 1H), 2.11 (s,
3H). 13C NMR (125 MHz, CDCl3) δ 170.68, 162.67 (d,
JcF = 249 Hz), 133.79, 133.71, 131.91, 122.60, 118.18,
115.68, 115.50, 85.44, 84.22, 64.25, 63.83, 63.36, 21.07.
HRMS (ESI): m/z Calculated for [M + Na]+ C15H13FO3Na
283.0741, found 283.0729.
1-(4,6-di-O-benzoyl-2,3-dideoxy-α-D-threo-hex-2-
enopyranosyl)-2-phenylacetylene(16a) 1H NMR (500 MHz,
CDCl3) δ 8.08–8.02 (m, 4H), 7.62–7.27 (m, 11H), 6.22 (p,
J = 10.2 Hz, 2H), 5.45 (d, J = 1.9 Hz, 1H), 5.34 (d, J = 1.6 Hz,
1H), 4.76–4.62 (m, 2H), 4.55 (dd, J = 11.1, 4.7 Hz, 1H).
HRMS (ESI): m/z Calculated for [M + Na]+ C28H22O5Na
461.1359, found 461.1375.
1-(4-O-acetyl-2,3,6-trideoxy-α-L-erythro-hex-2-
enopyranosyl)-2-phenylacetylene (12a) 1H NMR
(500 MHz, CDCl3) δ 7.52–7.41 (m, 2H), 7.32 (dd, J = 6.0,
1-(4,6-di-O-benzoyl-2,3-dideoxy-α-D-threo-hex-2-
enopyranosyl)-(m-tolylethynyl) (17a) H NMR (500 MHz,
CDCl3) δ 8.05 (m, 4H), 7.55 (dt, J = 21.1, 7.3 Hz, 2H), 7.41
1